Lialda Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Lialda
D
- D-Gam Anti-D (rho (d) immune globulin)
- Daypro (oxaprozin)
- Daypro Alta (oxaprozin)
- deferasirox
- Delstrigo (doravirine / lamivudine / tenofovir)
- Descovy (emtricitabine / tenofovir alafenamide)
- dexamethasone / ketorolac / moxifloxacin
- DiaBeta (glyburide)
- Diabinese (chlorpropamide)
- diatrizoate
- diatrizoate / iodipamide
- diclofenac
- diclofenac / misoprostol
- dicumarol
- Didronel (etidronate)
- Didronel IV (etidronate)
- diflunisal
- dimethyl fumarate
- diphenhydramine / ibuprofen
- diphenhydramine / naproxen
- diroximel fumarate
- Disalcid (salsalate)
- Dolobid (diflunisal)
- doravirine / lamivudine / tenofovir
- Dristan Sinus (ibuprofen / pseudoephedrine)
- Dual Action Pain Relief (acetaminophen / ibuprofen)
- Duetact (glimepiride / pioglitazone)
- Duexis (famotidine / ibuprofen)
- Duphalac (lactulose)
- DurAct (bromfenac)
- Dyloject (diclofenac)
- Dymelor (acetohexamide)
More about Lialda (mesalamine)
- Lialda consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (105)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: 5-aminosalicylates
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.